1,308
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Comparative study of the inhibitory effect of antidepressants on cholinesterase activity in Bungarus sindanus (krait) venom, human serum and rat striatum

, , , , , , & show all
Pages 912-917 | Received 16 Jul 2007, Accepted 01 Oct 2007, Published online: 20 Oct 2008

Figures & data

Figure 1. Chemical structure of paroxetine (A), sertraline (B), imipramine (C) and clomipramine (D).

Figure 1.  Chemical structure of paroxetine (A), sertraline (B), imipramine (C) and clomipramine (D).

Figure 2. Acetylcholinesterase (AChE) and butrylcholinesterase (BChE) experiments in the presence of 0.5 mM of antidepressants (Clom; clomipramine, Sert; sertraline, Paro; paroxetine and Imip; imipramine). Hydrolysis rates were measured at 412 nm by using 0.4 mM substrate in 1 mL assay solutions with 62 mM phosphate buffer (pH 7.5) and 1 mM DTNB [5,5-dithiobis(2-nitronenzoic acid)]. Enzyme was preincubated for 30 min before 0.4 mM substrate addition. For AChE activity, 0.06 mM ethopropazine (specific inhibitor of BChE) was used to inhibit the activity of BChE in snake venom. All experiments were repeated at least three times and similar results were obtained. For snake venom AChE *P < 0.05 and for human serum BChE *P < 0.038. Significantly different from control.

Figure 2.  Acetylcholinesterase (AChE) and butrylcholinesterase (BChE) experiments in the presence of 0.5 mM of antidepressants (Clom; clomipramine, Sert; sertraline, Paro; paroxetine and Imip; imipramine). Hydrolysis rates were measured at 412 nm by using 0.4 mM substrate in 1 mL assay solutions with 62 mM phosphate buffer (pH 7.5) and 1 mM DTNB [5,5-dithiobis(2-nitronenzoic acid)]. Enzyme was preincubated for 30 min before 0.4 mM substrate addition. For AChE activity, 0.06 mM ethopropazine (specific inhibitor of BChE) was used to inhibit the activity of BChE in snake venom. All experiments were repeated at least three times and similar results were obtained. For snake venom AChE *P < 0.05 and for human serum BChE *P < 0.038. Significantly different from control.

Figure 3. The graphs show rat brain striatum acetylcholinesterase experiments in the presence of 0.5 mM different antidepressants (Clom; clomipramine, Sert; sertraline, Paro; paroxetine and Imip; imipramine). Hydrolysis rates were measured at 412 nm by using 0.4 mM substrate in 1 mL assay solutions with 62 mM phosphate buffer (pH 7.5), and 1 mM DTNB [5,5-dithiobis(2-nitronenzoic acid)]. Enzyme was preincubated for 30 min before 0.4 mM substrate addition. 0.06 mM ethopropazine (specific inhibitor of BChE) was used to inhibit BChE activity. All experiments were repeated at least three times and similar results were obtained.

Figure 3.  The graphs show rat brain striatum acetylcholinesterase experiments in the presence of 0.5 mM different antidepressants (Clom; clomipramine, Sert; sertraline, Paro; paroxetine and Imip; imipramine). Hydrolysis rates were measured at 412 nm by using 0.4 mM substrate in 1 mL assay solutions with 62 mM phosphate buffer (pH 7.5), and 1 mM DTNB [5,5-dithiobis(2-nitronenzoic acid)]. Enzyme was preincubated for 30 min before 0.4 mM substrate addition. 0.06 mM ethopropazine (specific inhibitor of BChE) was used to inhibit BChE activity. All experiments were repeated at least three times and similar results were obtained.

Figure 4. Kinetic analysis of inhibition of snake venom acetylcholinesterase by Paroxetine (A) Sertraline (B) Imipramine (C) and Clomipramine (D).

Figure 4.  Kinetic analysis of inhibition of snake venom acetylcholinesterase by Paroxetine (A) Sertraline (B) Imipramine (C) and Clomipramine (D).

Table I. Ki and IC50 values for venom acetylcholinesterase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.